A Study to Evaluate the Pharmacokinetics and Safety of HIP1701 in Healthy Subjects
Clinical trial NCT04087525 · COMPLETED
Trial details
- NCT number
- NCT04087525
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-23
- Primary completion
- 2018-11-27
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.